Thyroid Hormones and Cardiovascular Function and Diseases.

[1]  Shangtong Lei.  Interpretation for surgical section of 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis , 2018 .

[2]  Фадеев Валентин Викторович,et al.  Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. , 2017 .

[3]  O. Franco,et al.  Association of Thyroid Function With Life Expectancy With and Without Cardiovascular Disease: The Rotterdam Study , 2017, JAMA internal medicine.

[4]  Amit Kumar,et al.  Usefulness of Serum Triiodothyronine (T3) to Predict Outcomes in Patients Hospitalized With Acute Heart Failure. , 2017, The American journal of cardiology.

[5]  Wei Fang,et al.  Free Triiodothyronine Level Correlates with Myocardial Injury and Prognosis in Idiopathic Dilated Cardiomyopathy: Evidence from Cardiac MRI and SPECT/PET Imaging , 2016, Scientific Reports.

[6]  Indhu Aynipullya Jayasingh,et al.  Subclinical hypothyroidism and the risk of hypercholesterolemia , 2016, Journal of family medicine and primary care.

[7]  T. Kirkwood,et al.  Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study , 2016, The Journal of clinical endocrinology and metabolism.

[8]  T. Anzai,et al.  Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure , 2016, ESC heart failure.

[9]  P. Grigolini,et al.  Cardioprotection and thyroid hormones , 2016, Heart Failure Reviews.

[10]  I. Klein,et al.  Thyroid Disease and the Heart. , 2016, Current problems in cardiology.

[11]  A. Belló-Klein,et al.  Thyroid hormones improve cardiac function and decrease expression of pro-apoptotic proteins in the heart of rats 14 days after infarction , 2016, Apoptosis.

[12]  B. Nygaard,et al.  Long‐term L‐Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double‐blind, cross‐over, placebo‐controlled intervention study , 2015, Clinical endocrinology.

[13]  D. Schlessinger,et al.  No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[14]  E. Fliers,et al.  Thyroid function in critically ill patients. , 2015, The lancet. Diabetes & endocrinology.

[15]  L. Hegedüs,et al.  The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism , 2015, European Thyroid Journal.

[16]  Pingan Chen,et al.  Free Triiodothyronine Levels and Short-Term Prognosis in Chronic Heart Failure Patients With Type 2 Diabetes , 2015, The American journal of the medical sciences.

[17]  T. Jernberg,et al.  Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. , 2015, European heart journal.

[18]  A. Zaman,et al.  Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial , 2015, Trials.

[19]  Connie M. Rhee,et al.  A review: Radiographic iodinated contrast media-induced thyroid dysfunction. , 2015, The Journal of clinical endocrinology and metabolism.

[20]  S. Razvi,et al.  Thyroid disease and vascular risk. , 2014, Clinical medicine.

[21]  G. Berghe.  Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces , 2014 .

[22]  O. Franco,et al.  Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis , 2014, European Journal of Epidemiology.

[23]  P. Larsen,et al.  N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial. , 2014, The Journal of clinical endocrinology and metabolism.

[24]  L. Pitto,et al.  Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis. , 2014, Endocrinology.

[25]  S. Mooijaart.  Letter regarding the Paper by Pearce et al. Entitled ‘2013 ETA Guideline: Management of Subclinical Hypothyroidism' , 2014, European Thyroid Journal.

[26]  J. Olesen,et al.  Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. , 2014, The Journal of clinical endocrinology and metabolism.

[27]  A. Zaman,et al.  Blood thrombogenicity is independently associated with serum TSH levels in post-non-ST elevation acute coronary syndrome. , 2014, The Journal of clinical endocrinology and metabolism.

[28]  I. Komuro,et al.  Circulating p53-Responsive MicroRNAs Are Predictive Indicators of Heart Failure After Acute Myocardial Infarction , 2013, Circulation research.

[29]  Daniel B Mark,et al.  Thyroid function in heart failure and impact on mortality. , 2013, JACC. Heart failure.

[30]  B. Biondi.  Mechanisms in endocrinology: Heart failure and thyroid dysfunction. , 2012, European journal of endocrinology.

[31]  R. Luben,et al.  Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts , 2012, Circulation.

[32]  J. Franklyn,et al.  Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. , 2012, Archives of internal medicine.

[33]  S. Pearce,et al.  Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. , 2012, Archives of internal medicine.

[34]  B. Biondi,et al.  Subclinical thyroid disease , 2012, The Lancet.

[35]  Connie M. Rhee,et al.  Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. , 2012, Archives of internal medicine.

[36]  V. Lorenzoni,et al.  Persistence of Mortality Risk in Patients With Acute Cardiac Diseases and Mild Thyroid Dysfunction , 2012, The American journal of the medical sciences.

[37]  K. Cao,et al.  Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction , 2011, Acta Pharmacologica Sinica.

[38]  L. Hegedüs,et al.  A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. , 2011, European journal of endocrinology.

[39]  Yunfei Cai,et al.  Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data , 2011, Hypertension Research.

[40]  G. Lippi,et al.  Hyperthyroidism and Venous Thrombosis: A Casual or Causal Association? A Systematic Literature Review , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[41]  H. Biter,et al.  Prevalence of Subclinical Hypothyroidism among Patients with Acute Myocardial Infarction , 2011, ISRN endocrinology.

[42]  M. Dimopoulos,et al.  Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? , 2011, European journal of endocrinology.

[43]  I. Mourouzis,et al.  Thyroid Hormone and Cardiac Disease: From Basic Concepts to Clinical Application , 2011, Journal of thyroid research.

[44]  T. Şahin,et al.  Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. , 2011, Endocrine journal.

[45]  W. Paulus,et al.  Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. , 2011, Endocrinology.

[46]  B. Biondi,et al.  Cardiovascular involvement in patients with different causes of hyperthyroidism , 2010, Nature Reviews Endocrinology.

[47]  Herng‐Ching Lin,et al.  Hyperthyroidism and Risk of Ischemic Stroke in Young Adults: A 5-Year Follow-Up Study , 2010, Stroke.

[48]  M. Vanderpump,et al.  The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. , 2010, The Journal of clinical endocrinology and metabolism.

[49]  P. Lavori,et al.  Response to Letter Regarding Article, “DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial Veterans Affairs Cooperative Study” , 2010 .

[50]  R. Luben,et al.  Initial thyroid status and cardiovascular risk factors: The EPIC‐Norfolk prospective population study , 2010, Clinical endocrinology.

[51]  A. Pingitore,et al.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence , 2010, Heart Failure Reviews.

[52]  F. Laurindo,et al.  Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. , 2010, Cardiovascular research.

[53]  V. Lionetti,et al.  Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats , 2010, Journal of cellular and molecular medicine.

[54]  Jincheng Li,et al.  miR-30 Regulates Mitochondrial Fission through Targeting p53 and the Dynamin-Related Protein-1 Pathway , 2010, PLoS genetics.

[55]  E. Olson,et al.  A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. , 2009, Developmental cell.

[56]  U. John,et al.  Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study. , 2009, European journal of endocrinology.

[57]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[58]  M. Emdin,et al.  Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. , 2009, Journal of cardiac failure.

[59]  P. Renard,et al.  Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion? , 2009, Basic Research in Cardiology.

[60]  W. Dillmann.  Cardiac hypertrophy and thyroid hormone signaling , 2009, Heart Failure Reviews.

[61]  C. Forleo,et al.  Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. , 2008, Current pharmaceutical design.

[62]  H. Völzke,et al.  The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area. , 2008, European journal of endocrinology.

[63]  T. Visser,et al.  Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. , 2008, Molecular endocrinology.

[64]  A. L'Abbate,et al.  Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. , 2008, The Journal of clinical endocrinology and metabolism.

[65]  K. Kopecky,et al.  Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. , 2008, The Journal of clinical endocrinology and metabolism.

[66]  B. Biondi,et al.  The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.

[67]  R. H. Costa-e-Sousa,et al.  Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. , 2007, Endocrinology.

[68]  H. Vierhapper,et al.  Altered platelet plug formation in hyperthyroidism and hypothyroidism. , 2007, The Journal of clinical endocrinology and metabolism.

[69]  A. L'Abbate,et al.  Association between increased mortality and mild thyroid dysfunction in cardiac patients. , 2007, Archives of internal medicine.

[70]  H. Saconato,et al.  Thyroid hormone replacement for subclinical hypothyroidism. , 2007, The Cochrane database of systematic reviews.

[71]  R. Sabit,et al.  Thyroid disease and vascular function. , 2007, Thyroid : official journal of the American Thyroid Association.

[72]  J. Weaver,et al.  The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.

[73]  C. Lau,et al.  Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. , 2007, The Journal of clinical endocrinology and metabolism.

[74]  C. Xinaris,et al.  Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction , 2007, Basic Research in Cardiology.

[75]  L. Vatten,et al.  The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. , 2007, European journal of endocrinology.

[76]  L. Ghiadoni,et al.  Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. , 2006, The Journal of clinical endocrinology and metabolism.

[77]  U. John,et al.  The association between subclinical hyperthyroidism and blood pressure in a population-based study , 2006, Journal of hypertension.

[78]  G. Cella,et al.  Hyperthyroidism as a Cause of Pulmonary Arterial Hypertension: A Prospective Study , 2006, Angiology.

[79]  M. Emdin,et al.  Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. , 2006, Journal of cardiac failure.

[80]  R. Delsignore,et al.  Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. , 2006, European journal of internal medicine.

[81]  R. Jorde,et al.  Serum lipid levels in relation to serum thyroid‐stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study , 2006, Journal of internal medicine.

[82]  C. Erem.  Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity , 2006, Clinical endocrinology.

[83]  U. John,et al.  Low serum thyrotropin is associated with high plasma fibrinogen. , 2006, The Journal of clinical endocrinology and metabolism.

[84]  Peter O'Leary,et al.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. , 2005, Archives of internal medicine.

[85]  E. Vittinghoff,et al.  Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. , 2005, Archives of internal medicine.

[86]  C. Long,et al.  Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. , 2005, Molecular endocrinology.

[87]  S. Guldıken,et al.  Global fibrinolytic capacity in patients with subclinical hypothyroidism. , 2005, Endocrine journal.

[88]  N. Kamel,et al.  Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. , 2005, European journal of endocrinology.

[89]  N. Osman,et al.  Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. , 2005, Journal of the American College of Cardiology.

[90]  A. L'Abbate,et al.  Triiodothyronine levels for risk stratification of patients with chronic heart failure. , 2005, The American journal of medicine.

[91]  Paul Webb,et al.  Thyroxine-Thyroid Hormone Receptor Interactions* , 2004, Journal of Biological Chemistry.

[92]  A. D. de Craen,et al.  Thyroid status, disability and cognitive function, and survival in old age. , 2004, JAMA.

[93]  P. Vestergaard,et al.  Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. , 2004, Archives of internal medicine.

[94]  J. Kvetny,et al.  Subclinical hypothyroidism is associated with a low‐grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years , 2004, Clinical endocrinology.

[95]  A. Hida,et al.  Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. , 2004, The Journal of clinical endocrinology and metabolism.

[96]  V. Palmieri,et al.  Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. , 2004, European journal of endocrinology.

[97]  U. John,et al.  Thyroid function and carotid wall thickness. , 2004, The Journal of clinical endocrinology and metabolism.

[98]  C. Palombo,et al.  Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. , 2004, The Journal of clinical endocrinology and metabolism.

[99]  P. Thompson,et al.  Treating hypothyroidism improves endothelial function. , 2004, Metabolism: clinical and experimental.

[100]  I. Klein,et al.  Thyroid hormone and blood pressure regulation , 2003, Current hypertension reports.

[101]  C. Duman,et al.  Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. , 2003, Thyroid : official journal of the American Thyroid Association.

[102]  L. Ghiadoni,et al.  Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[103]  P. Ladenson,et al.  Hypothyroidism and atherosclerosis. , 2003, The Journal of clinical endocrinology and metabolism.

[104]  C. Erem,et al.  BLOOD COAGULATION AND FIBRINOLYTIC ACTIVITY IN HYPOTHYROIDISM , 2003, International journal of clinical practice.

[105]  A. L'Abbate,et al.  Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease , 2003, Circulation.

[106]  Joshua R. Smith,et al.  Increased central arterial stiffness in hypothyroidism. , 2002, The Journal of clinical endocrinology and metabolism.

[107]  T. Visser,et al.  Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. , 2002, Endocrinology.

[108]  L. Friberg,et al.  Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? , 2002, Archives of internal medicine.

[109]  J. Dernellis,et al.  Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. , 2002, American heart journal.

[110]  L. Duntas.  Thyroid disease and lipids. , 2002, Thyroid : official journal of the American Thyroid Association.

[111]  L. Friberg,et al.  Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. , 2001, The American journal of medicine.

[112]  J. Franklyn,et al.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.

[113]  T. Kanda,et al.  Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infarction. , 2001, Research communications in molecular pathology and pharmacology.

[114]  E. Ferrannini,et al.  Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. , 2001, The Journal of clinical endocrinology and metabolism.

[115]  B. Müller,et al.  Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease , 2001, European journal of clinical investigation.

[116]  P. Giral,et al.  Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. , 2001, The Journal of clinical endocrinology and metabolism.

[117]  T. Tzotzas,et al.  Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. , 2000, Thyroid : official journal of the American Thyroid Association.

[118]  T. Kanda,et al.  Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. , 2000, European journal of endocrinology.

[119]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[120]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[121]  B. Biondi,et al.  Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[122]  C. Morillas,et al.  Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. , 1998, Mayo Clinic proceedings.

[123]  T. Bucciarelli,et al.  Effect of thyroid function on LDL oxidation. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[124]  J. Lekakis,et al.  Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. , 1997, Thyroid : official journal of the American Thyroid Association.

[125]  F. B. Davis,et al.  Nongenomic actions of thyroid hormone. , 1996, Thyroid : official journal of the American Thyroid Association.

[126]  R. Westendorp,et al.  Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies , 1996, Clinical endocrinology.

[127]  J. Franklyn,et al.  Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. , 1996, Heart.

[128]  S. Thomas,et al.  Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.

[129]  F. Sánchez‐Madrid,et al.  Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders , 1995, Clinical and experimental immunology.

[130]  D. Appleton,et al.  LIPID PROFILES AND CARDIOVASCULAR DISEASE IN THE WHICKHAM AREA WITH PARTICULAR REFERENCE TO THYROID FAILURE , 1977, Clinical endocrinology.

[131]  J. Jiskra,et al.  [Thyroid hormones and cardiovascular system]. , 2018, Vnitrni lekarstvi.

[132]  A. Zaman,et al.  Thyroid hormones and cardiovascular disease , 2017, Nature Reviews Cardiology.

[133]  I. Erdinler,et al.  Sick euthyroid syndrome is associated with poor prognosis in patients with ST segment elevation myocardial infarction undergoing primary percutaneous intervention. , 2014, Cardiology journal.

[134]  G. Van den Berghe.  Non-thyroidal illness in the ICU: a syndrome with different faces. , 2014, Thyroid : official journal of the American Thyroid Association.

[135]  G. Brabant,et al.  ETA Guideline : Management of Subclinical Hypothyroidism , 2013 .

[136]  Yawei Xu,et al.  A low fT3 level as a prognostic marker in patients with acute myocardial infarctions. , 2012, Internal medicine.

[137]  I. Klein.  Endocrine Disorders and Cardiovascular Disease , 2012 .

[138]  H. Büller,et al.  Thyroid disease and haemostasis : a relationship with clinical implications ? , 2010 .

[139]  I. Klein,et al.  Effects of amiodarone therapy on thyroid function , 2010, Nature Reviews Endocrinology.

[140]  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The mechanisms of atrial fibrillation in hyperthyroidism , 2009 .

[141]  M. Schott.  Acute Effects of Triiodothyronine (T3) Replacement Therapy in Patients with Chronic Heart Failure and Low-T3 Syndrome: A Randomized, Placebo-Controlled Study , 2008 .

[142]  E. Mazzaferri.  Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .

[143]  B. Biondi,et al.  Effects of thyroid hormone on the cardiovascular system. , 2004, Recent progress in hormone research.

[144]  L. J. Groot,et al.  Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .

[145]  L. D. De Groot.  Dangerous dogmas in medicine: the nonthyroidal illness syndrome. , 1999, The Journal of clinical endocrinology and metabolism.

[146]  W. Wiersinga.  Propranolol and thyroid hormone metabolism. , 1991, Thyroid : official journal of the American Thyroid Association.

[147]  H. L. Bleich,et al.  Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. , 1982, The New England journal of medicine.

[148]  W M Wiersinga,et al.  Increased oxidizability of low-density lipoproteins in hypothyroidism. , 1998, The Journal of clinical endocrinology and metabolism.